The mechanism of enzyme regulation through conformational changes is a key pattern in governing cell behavior. In this thesis the focus is on three protein complexes that reflect how protein activity can be regulated by different effectors. Different spectroscopic techniques, like IR and Raman spectroscopy, were used is order to follow the secondary and tertiary conformational changes in protein structure to identify their roles. The first protein of interest was PDZ1 from MAGI-1, involved in cellular signaling. This scaffold domain is known to interact with the E6 protein from HPV16. It was demonstrated that the different conformational states and their affinities to the C-terminus of the viral protein is regulated by the dynamics of the hydrogen bonding network formed by the connection of specific amino acids in three regions of the protein. Study of mutations around the C-terminal area of the protein and the βC strand were performed; demonstrating that both regions are crucial for assembly of the hydrogen bonding network to stabilize the substrate binding. These results leads to conclude that the pathogenicity and prevalence of a particular virus like HPV16 is in its ability to build a stronger hydrogen bonding network in comparison to the natural binder. The allosteric model and the "shift population" model agree that, upon binding, conformational changes distant from a carboxylate binding group might be the key to understanding the binding dynamics between the PDZ domains and the viral proteins.The second protein of interest was a model that constitutes a small scale prototype of the conformational changes observed in more complex proteins; it is a short Copper-binding peptide, the amyloid-beta peptide, known to beinvolved in Alzheimer's disease. The objective with this model was to describe the effect of histidine ligands in the metal centers upon Copper (Cu) reduction, a key electrochemical reaction in the development of Alzheimer's. FTIR difference spectroscopy showed two different spheres of coordination for Cu(II) and Cu(I). The major changes in the structure are dominated by the contribution of the imidazole ring of His residues (His6, His13 and His14), in addition to Asp1 and Tyr10 residues. Changes in the coordination geometry could be key to the pH-dependency of the aggregation observed in the presence of Cu(I). Accordingly, it can be suggested that the formation of the fibrils observed in Alzheimer's patients is not only triggered by the presence of Cu but it is strongly affected by its redox state. The last system of interest was a metalloprotein, the NADH:ubiquinone oxidoreductase (complex I), which plays a key role in the cellular bioenergetics. This protein bears several Fe-S clusters and one flavin and its activity is regulated by the energy produced by a bound substrate and the electron transfer of its cofactors. The metal ligand-vibrations of the cofactors are described in their oxidized and reduced states. Using electrochemistry coupled to FTIR, Resonance Raman and Fluorescence spectroscopies, the investigation of complex I led to the conclusion that the properties of the metal centers are dictated, to a large extent, by their surrounding environment. [...]

Submitted by LILIAN HERNÁNDEZ ALVAREZ null (lilianhern@gmail.com) on 2017-10-16T13:40:19Z No. of bitstreams: 1 Lilian_dissertacao_final.pdf: 8133270 bytes, checksum: ea7913c9f03bc3c89f0211896c01cc88 (MD5) / Approved for entry into archive by Monique Sasaki (sayumi_sasaki@hotmail.com) on 2017-10-18T17:58:56Z (GMT) No. of bitstreams: 1 hernandezalvarez_l_me_sjrp.pdf: 8133270 bytes, checksum: ea7913c9f03bc3c89f0211896c01cc88 (MD5) / Made available in DSpace on 2017-10-18T17:58:56Z (GMT). No. of bitstreams: 1 hernandezalvarez_l_me_sjrp.pdf: 8133270 bytes, checksum: ea7913c9f03bc3c89f0211896c01cc88 (MD5) Previous issue date: 2017-09-29 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Trypanosoma cruzi é o agente causal da doença de Chagas, uma infecção negligenciada que afeta milhões de pessoas nas regiões tropicais. A maioria dos fármacos empregados no tratamento desta doença são altamente tóxicos e geram resistência. Na atualidade, o descobrimento de inibidores alostéricos é um tópico emergente dentro da área de desenho computacional de fármacos, pois promove a acessibilidade a medicamentos mais seletivos e menos tóxicos. Neste trabalho foi desenvolvida uma estratégia para a descoberta computacional de inibidores alostéricos a qual foi aplicada à cruzaína, a principal cisteíno protease do T. cruzi. A caracterização molecular da forma livre e ligada da cruzaína foi investigada através do ancoramento molecular, simulações de dinâmica molecular, cálculos de energia livre de ligação e construção de redes de interações entre resíduos. A partir da análise baseada na geometria das estruturas geradas na dinâmica molecular, foram detectados dois potenciais sítios alostéricos na cruzaína. Os resultados sugerem a existência de diferentes mecanismos de regulação exercidos pela ligação de inibidores diferentes no mesmo sítio alostérico. Além disso, foram identificados os resíduos que estabelecem os caminhos de transmissão de informação entre um dos sítios alostéricos identificado e o sítio ativo da enzima. O presente estudo é a primeira aproximação de desenho de inibidores alostéricos da cruzaína e serve para futuras intervenções farmacológicas. Esses resultados constituem uma base para o desenho de inibidores específicos de cisteíno proteases homólogas da papaína. / Trypanosoma cruzi is the causative agent of Chagas disease, a neglected infection affecting millions of people in tropical regions. There are several chemotherapeutic agents for the treatment of this disease, but most of them are highly toxic and generate resistance. Currently, the development of allosteric inhibitors constitutes a promising research field, since it may improve the accessibility to more selective and less toxic medicines. To date, the allosteric drugs prediction is a state-of-the-art topic in rational structure-based computational design. In this work a simulation strategy was developed for computational discovery of allosteric inhibitors, and it was applied for or cruzain, a promising target and the major cysteine protease of T. cruzi. Molecular dynamics simulations, binding free energy calculations and network-based modelling of residue interactions were combined to characterize and compare molecular distinctive features of the apo form and the cruzain-allosteric inhibitor complexes. By using geometry-based detection on trajectory snapshots we determined the existence of two main allosteric sites suitable for drug targeting. The results suggest dissimilar mechanism exerted by the same allosteric site when binding different potential allosteric inhibitors. Finally, we identified the residues involved in suboptimal paths linking the identified site and the orthosteric site. The present study constitutes the first approximation for designing cruzain allosteric inhibitors and may serve for future pharmacological intervention. These findings are particularly relevant for the design of allosteric modulators of papain-like cysteine proteases. / CAPES: 031/2013

Le mécanisme de régulation des enzymes à travers les changements conformationnels est un processus clé dans le contrôle du fonctionnement cellulaire. Cette thèse est focalisée sur l’étude de trois complexes protéiques qui reflètent comment l’activité de protéines peut être est régulée par différents effecteurs. Pour cela, différentes spectroscopies ont étaient utilisées pour suivre les changements conformationnels des structures secondaire et tertiaire d’une protéine. La première protéine d’intérêt est PDZ1 de MAGI-1, impliquées dans la signalisation cellulaire. Ce domaine d’échafaudage est connu d’interagir avec la protéine E6 de HPV16. Il était démontré que les différents états conformationnels et leurs affinités vis-à-vis le C-terminal de la protéine virale sont régulées par la dynamique des liaisons hydrogène formées par un réseau qui connecte des acides aminés localisés dans les trois domaines de la protéine. Ces résultats suggère que les différences d’affinités sont directement corrélées aux liaisons hydrogène, ce qui mène à conclure que la pathogénicité et la prévalence d’un virus particulier comme le HPV16 sont liées à son habilitée à former un réseau de liaison hydrogène très solide comparé au substrat naturel. La deuxième protéine d’intérêt est une protéine modèle qui représente un petit prototype du changement conformationnel observé dans des protéines plus complexes. Il s’agit d’un peptide court capable de coordonner le cuivre. Ce n’est autre que le peptide β-amyloïde, connu d’être impliqué dans la maladie d’Alzheimer. L’objectif ici est de décrire l’effet des ligands histidine lors de la réduction du cuivre, qui est une réaction électrochimique critique pour le développement d’Alzheimer. La spectroscopie IRTF différentielle a montré deux sphères de coordination pour le Cu(I) et le Cu(II). Les majeurs changements spectraux sont dominés par les vibrations de l’imidazole des différentes histidines (His6, His13 et His14) ainsi que la contribution des résidus Asp1 et Tyr10. Les modifications de la géométrie de coordination peuvent être la cause de la dépendance-pH de l’agrégation du peptide observée en présence du Cu(I). Pour cela, il est possible de suggérer que la formation des fibrilles observées chez les patients d’Alzheimer n’est pas seulement stimulée par la présence du cuivre même mais elle est fortement affectée par ses réactions rédox.La dernière protéine d’intérêt est une métalloprotéine, la NADH:ubiquinone oxidoréductase (complexe I), qui joue un rôle majeur dans la bioénergétique cellulaire. Cette protéine contient plusieurs centres Fe-S et une flavine et son activité est régulée par l’énergie produite par la liaison avec un substrat ainsi que le transfert d’électrons de ces cofacteurs. Les vibrations métal-ligands de ces cofacteurs à l’état oxydé et à l’état réduit sont décrites ici. En utilisant l’électrochimie couplée aux spectroscopies IRTF, Raman de résonance et de fluorescence, les investigations sur le complexe I ont conduit à conclure que les propriétés des centres métalliques sont largement influencées par l’environnement proche. De plus, les changements conformationnels de la protéine ont un effet considérable sur les propriétés rédox et par la même, sur le bon fonctionnement de la protéine. Par ailleurs, la mutagenèse dirigée était utilisée pour étudier les propriétés des centres N1a et N2. A part des cofacteurs métalliques, cette étude a montré l’existence d’un nouveau cofacteur, une quinone localisée proche du domaine membranaire.[...] / The mechanism of enzyme regulation through conformational changes is a key pattern in governing cell behavior. In this thesis the focus is on three protein complexes that reflect how protein activity can be regulated by different effectors. Different spectroscopic techniques, like IR and Raman spectroscopy, were used is order to follow the secondary and tertiary conformational changes in protein structure to identify their roles. The first protein of interest was PDZ1 from MAGI-1, involved in cellular signaling. This scaffold domain is known to interact with the E6 protein from HPV16. It was demonstrated that the different conformational states and their affinities to the C-terminus of the viral protein is regulated by the dynamics of the hydrogen bonding network formed by the connection of specific amino acids in three regions of the protein. Study of mutations around the C-terminal area of the protein and the βC strand were performed; demonstrating that both regions are crucial for assembly of the hydrogen bonding network to stabilize the substrate binding. These results leads to conclude that the pathogenicity and prevalence of a particular virus like HPV16 is in its ability to build a stronger hydrogen bonding network in comparison to the natural binder. The allosteric model and the “shift population” model agree that, upon binding, conformational changes distant from a carboxylate binding group might be the key to understanding the binding dynamics between the PDZ domains and the viral proteins.The second protein of interest was a model that constitutes a small scale prototype of the conformational changes observed in more complex proteins; it is a short Copper-binding peptide, the amyloid-beta peptide, known to beinvolved in Alzheimer’s disease. The objective with this model was to describe the effect of histidine ligands in the metal centers upon Copper (Cu) reduction, a key electrochemical reaction in the development of Alzheimer’s. FTIR difference spectroscopy showed two different spheres of coordination for Cu(II) and Cu(I). The major changes in the structure are dominated by the contribution of the imidazole ring of His residues (His6, His13 and His14), in addition to Asp1 and Tyr10 residues. Changes in the coordination geometry could be key to the pH-dependency of the aggregation observed in the presence of Cu(I). Accordingly, it can be suggested that the formation of the fibrils observed in Alzheimer’s patients is not only triggered by the presence of Cu but it is strongly affected by its redox state. The last system of interest was a metalloprotein, the NADH:ubiquinone oxidoreductase (complex I), which plays a key role in the cellular bioenergetics. This protein bears several Fe-S clusters and one flavin and its activity is regulated by the energy produced by a bound substrate and the electron transfer of its cofactors. The metal ligand-vibrations of the cofactors are described in their oxidized and reduced states. Using electrochemistry coupled to FTIR, Resonance Raman and Fluorescence spectroscopies, the investigation of complex I led to the conclusion that the properties of the metal centers are dictated, to a large extent, by their surrounding environment. [...]

STAT5 est une protéine de la signalisation cellulaire normale, qui peut jouer un rôle important dans la transformation, la survie et à la résistance aux inhibiteurs de tyrosine kinase des cellules tumorales. Son activation constitutive par phosphorylation est liée à la présence de protéines oncogéniques comme la protéine de fusion BCR/ABL1 (leucémie myéloïde chronique) ou de formes mutées de KIT (mastocytoses), par exemple. L’inhibition pharmacologique de STAT5 constitue donc un enjeu thérapeutique majeur pour plusieurs pathologies malignes. Nous avons réalisé la première modélisation et les simulations de dynamique moléculaire des principales formes de STAT5 : la forme monomérique cytoplasmique phosphorylée ou non, et la forme dimérique phosphorylée et liée à l’ADN. Nous avons caractérisé les propriétés dynamiques et le réseau allostérique intramoléculaire des monomères de STAT5. Les résultats générés montrent des variations structurales et dynamiques liées à la différence de séquence primaire des isoformes de STAT5 et/ou à la présence du groupement phosphate. Deux poches à la surface des protéines ont également été caractérisées. Leur localisation à proximité de voies de communication allostériques suggère que ces poches pourraient constituer des sites de modulation des fonctions de STAT5. Nous avons également caractérisé les liaisons hydrogènes entre les monomères constituant les dimères de STAT5 et leur reconnaissance de l’ADN. En outre, nous avons identifié des résidus clés aux interfaces entre les entités moléculaires, nous permettant de mieux comprendre les effets de mutations de STAT5 observées en clinique dans certaines pathologies malignes. / STAT5 is a protein involved in normal cell signalling that is crucial for transformation, survival and resistance to tyrosine kinase inhibitors of tumour cells. The constitutive phosphorylation activates STAT5 and is related to oncogenic proteins like the hybrid protein BCR/ABL1 (chronic myeloid leukaemia) or mutated KIT receptor (mastocytosis). The pharmacologic inhibition of STAT5 is thus a major therapeutic concern in several malignant pathologies. We performed the first modelling and molecular dynamics simulations of the main cellular species of STAT5: the cytoplasmic phosphorylated or unphosphorylated monomer, and the phosphorylated dimer bound to DNA. We characterized the dynamical properties and the intramolecular allosteric network of the monomers. The generated results show structural and dynamic variations linked to the primary sequence changes between the two STAT5 isoforms and/or to the phosphate group. Two pockets were characterized at the surface of STAT5. Their location at close proximity of allosteric communication pathways suggests new putative inhibition sites to modulate STAT5 functions. We also described the hydrogen bonds network between the monomers of the dimeric species and the recognition of the DNA. We identified key residues at the interfaces, allowing us to better understand the effects of clinically relevant STAT5 mutations observed in malignancies.

Cette thèse est consacrée à la régulation de la guanylate cyclase soluble (sGC), le récepteur endogène du monoxyde d'azote (NO) chez les mammifères qui est impliqué dans la transduction du signal. L'enzyme sGC est activée par la fixation du NO sur son hème et catalyse alors la formation du cGMP à partir du GTP. Alors que la sGC est présente dans de nombreuses cellules de mammifères, le domaine hémique bactérien homologue (H-NOX) est impliqué dans la détection du NO et la régulation du métabolisme. Un objectif important est la découverte d'inhibiteurs de la sGC pour ralentir la progression tumorale.Le criblage de composés naturels d'une chimiothèque mesurant l'activité de la sGC purifiée a révélé six inhibiteurs actifs (Ki = 0.2 – 1 µM). Avec deux autres composés actifs en photothérapie (hypericin et hypocrellin) nous avons démontré que ces inhibiteurs sont des effecteurs allostériques qui ne se fixent ni sur l'hème, ni sur le site catalytique ou de fixation des activateurs, découvrant une nouvelle classe de composés pharmacologiques ciblant la voie de signalisation NO/cGMP.La transition structurale induite par l'activateur riociguat en synergie avec le CO a été étudiée par spectroscopie d'absorption résolue en temps pour démontrer des changements de coordination de l'hème. Deux états d'activation distincts de la sGC par le CO existent simultanément avec les coordiantions 6c-hème et 5c-hème en présence de l'activateur qui induit la rupture de la liaison Fe-His de l'hème, à l'instar de l'activateur naturel NO. De plus, nous montrons que l'isoliquiritigénine, commercialisée comme activateur de la sGC, et en réalité un inhibiteur de la sGC.La dynamique ds ligands CO, NO, and O2 a été mesurée sur 12 ordres de grandeur temporelle pour le type sauvage et un mutant du transporteur bactérien du NO (AXCP). La simple mutation Leu16Ala augmente l'afinité pour le CO 108 fois, celle du NO 106 fois et rend cette protéine réactive à O2. Dans le cas de CO et NO dont les affinités pour L16A-AXCP sont les plus grandes jamais mesurées, la recombinaison bimoléculaire n'est pas détectable. Des simulations de dynamique moléculaire ont démontré que le CO dissocié est contraint de rester à 4 Å du Fe2+ par Ala16, contrairement au type sauvage Leu16.La dynamique de O2 a été mesurée dans la protéine senseur Tt H-NOX par spectroscopie d'absorption transitoire et confirme l'hypothèse que Tt H-NOX n'est sans doute pas un senseur de NO stricto sensu mais un senseur redox. Les propriétés de Tt-H-NOX ne sont pas compatibles avec le rôle d'un simple transporteur de NO. / This thesis is devoted to the regulation of soluble guanylate cyclase (sGC), the endogenous nitric oxide (NO) receptor in mammals involved in signal transduction. The enzyme is activated by the binding of NO to its heme and catalyzes the formation of cGMP from GTP. While sGC is present in many mammalian cells, the homologous bacterial domain (H-NOX) is involved in NO detection and metabolism regulation. An important objective was to find sGC inhibitors to slow down tumor progression.The screening of natural compounds from a chemical library, tested on purified sGC activity, revealed six active inhibitors (Ki = 0.2 – 1 µM). Together with two agents for photodynamic therapy (hypericin and hypocrellin) we demonstrated that these inhibitors are allosteric modulators which bind neither to the heme nor to the catalytic and activator sites, revealing a new class of pharmacological compounds targetting the NO/cGMP signaling pathway.The structural transition induced in sGC by stimulator riociguat in synergy with CO was studied by transient absorption spectroscopy to demonstrate coordination changes of the heme. Two different activation states of sGC with CO 6c-heme and 5c-heme exist simultaneously in the presence of the stimulator which induces the breaking of the heme Fe-His bond, as does the sGC natural effector NO. In addition, the effect of isoliquiritigenin, which is sold as a sGC activator, was shown to be actually an inhibitor of sGC.The dynamics of the ligands CO, NO and O2 were measured over 12 orders of magnitude in time in wild type and mutant of a bacterial NO transporter (AXCP). The single mutation Leu16Ala increased 108-fold the CO affinity, ~106-fold the NO affinity and makes this protein reactive to O2. In the case of CO and NO, whose affinities for L16A-AXCP are the largest ever measured, the bimolecular rebinding was absolutely not detectable. Molecular dynamic simulations demonstrated that dissociated CO is constrained to stay within 4 Å from Fe2+ by Ala16, contrarily to wild-type Leu16.The dynamics of O2 in Tt-H-NOX proteins measured by transient absorption spectroscopy confirmed the hypothesis that Tt-H-NOX may not be a NO-sensor stricto sensu but a redox sensor. The properties of the Tt-H-NOX protein are not compatible with the role a mere NO-carrier.

No description available.

No description available.

No description available.

<p>Exchange proteins directly activated by cAMP (EPAC) are guanine nucleotide exchange factors for the small GTPases, Rap1 and Rap2. The central regulatory module of EPAC is a cAMP binding domain (CBD), which in the absence of cAMP provides auto-inhibition of the catalytic guanine nucleotide exchange activity. Binding of the allosteric effector, cAMP, removes the auto-inhibition exerted by the CBD of EPAC. Herein, we investigate through NMR spectroscopy the structural and dynamical basis of auto-inhibition and cAMP-dependent allosteric activation in the CBD of EPAC. Specifically, the work described in this dissertation proposes novel methods that utilize NMR chemical shifts to define the network of residues that mediates long-range intra-molecular signalling, <em>i.e.</em> the chemical shift covariance analysis (CHESCA) and the chemical shift projection analysis (CHESPA). Using CHESCA as explained in Chapter 2, we identified an allosteric network that bridges the sites of cAMP-binding and cAMP-dependent structural changes to those of cAMP-dependent dynamical changes, which are critical for the release of auto-inhibition. The CHESCA results therefore rationalize how cAMP leads to activation through modulation of both structure and dynamics. In order to dissect the determinants of auto-inhibition in the absence of cAMP, several mutations along the signaling pathways identified by CHESCA were implemented and their effect on the auto-inhibitory conformational equilibrium of the apo-CBD was assessed through CHESPA, as outlined in Chapters 3 and 4. Overall, we have shown how CHESCA and CHESPA provide unprecedented insight into the allosteric networks underlying auto-inhibition and cAMP dependent activation in the CBD of EPAC. In addition, the methods employed here to map EPAC allostery are likely to be generally applicable to other systems.</p> / Doctor of Philosophy (PhD)

Allostery is a regulatory process whereby a perturbation by an effector at one discrete locus creates a conformational change that stimulates a functional change at another. The two sites communicate through networks of interacting residues that respond in a concerted manner to the allosteric perturbation. These allosteric networks are traditionally mapped with high resolution structure determination techniques to understand the conformational changes that regulate protein function as well as its modulation by allosteric ligands and its dysfunction caused by disease-related mutations (DRMs). However, high resolution structural determination techniques, such as X-ray crystallography, cryo-electron microscopy and nuclear Overhauser effect NMR spectroscopy are not always amenable for systems plagued by poor solubility and line broadening caused by μs-ms dynamics or systems where allostery relies primarily on dynamical rather than structural changes. This dissertation discusses methodologies to map the allosteric sites and pathways for such challenging systems. The foundation of this approach is to model allosteric pathways in the context of their respective thermodynamic cycles. In chapter 2, the thermodynamic cycle of a DRM in the hyperpolarization-activated cyclic nucleotide-gated ion channel 4 (HCN4) is analyzed with respect to structure, dynamics and kinetics, revealing how the DRM remodels the free energy landscape of HCN4 and results in a loss-of-function disease phenotype. In chapter 3, the mechanism of action of an uncompetitive inhibitor for the exchange protein activated by cAMP is elucidated by characterizing its selectivity for distinct conformations within the thermodynamic cycle that are trapped using a combination of mutations and ligand analogs. In chapter 4, we discuss two new protocols for the chemical shift covariance analysis (CHESCA). The CHESCA is an approach that identifies allosteric signaling pathways by measuring concerted residue responses to a library of chemical perturbations that stabilize conformational equilibria at different positions. Overall, the approaches discussed in this dissertation are widely applicable for mapping the mechanisms of allosteric perturbations that arise from ligand binding, post-translational modifications and mutations, even in systems where traditional structure determination techniques remain challenging to implement. / Thesis / Doctor of Philosophy (PhD) / Allostery is a regulatory mechanism for proteins, which controls functional properties of one distinct site through the perturbation of another distinct, and often distant, site. The two sites are connected via a series of residues that undergo conformational changes once perturbed by the allosteric effector. Mapping these communication pathways reveals mechanisms of protein regulation, which are invaluable for developing pharmacological modulators to target these pathways or for understanding the mechanisms of disease mutations that disrupt these pathways. Allosteric pathways have been traditionally determined using structure determination approaches that provide a static snapshot of the protein’s structure. However, these approaches are typically not effective when allostery relies extensive changes in dynamics. The goal of this thesis was to develop methods to characterize systems that are dynamic or otherwise unsuitable for traditional structure determination. Herein, we utilize NMR spectroscopy to analyze the allosteric mechanisms of three cAMP-binding proteins involved in cardiovascular health.